UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
Sanofi SA ADR SNY
News
EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing — Update
EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing
Flu season is already here. Here's what to know about this year's flu shots.
Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®
Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal — Update
Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
European Pharma Leaders Push for National Reforms to Boost Investment
Sanofi to Take Stake in Cheplapharm in Swap for Drug Portfolio, Manufacturing Sites
Sanofi partners with USA Pickleball to launch "Serve Up Protection" campaign to help protect older adults from COVID-19 with NUVAXOVID™
Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
Sanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline
Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
Scribe Therapeutics to Sell 7.15 Million Shares at $13-$15 Each in IPO
EU Seeks Views on Sanofi's Concessions to End Competition Probe — Update
EU Seeks Views on Sanofi's Concessions to End Competition Probe
Sanofi Drug for Rare Neuromuscular Disease Hits Goals in Late-Stage Trial
United States